CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: First, CD34+/CD38− leukemic stem cells (LSCs) derived from patients with the chronic phase (CP) of chronic myeloid leukemia (CML) expressed CD26 at high levels.